Search Results - "Bottiglieri, Sal"
-
1
UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation
Published in Cancers (29-03-2021)“…Multi-gene assays often include and, in certain instances, may report associated toxicity risks for irinotecan, belinostat, pazopanib, and nilotinib. However,…”
Get full text
Journal Article -
2
PARP Inhibitors in Pancreatic Cancer with Homologous Recombination Repair Gene Mutations: A Single-Institution Experience
Published in Cancers (11-10-2024)“…Limited data are available regarding the anticancer activity of PARP inhibitors (PARPis) in pancreatic cancer with mutations in HRR genes other than and . We…”
Get full text
Journal Article -
3
Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566
Published in Cancers (25-10-2024)“…In the original publication [...]…”
Get full text
Journal Article -
4
Pharmacologic Prevention of Skeletal-related Events in Cancer Patients
Published in Orthopedics (Thorofare, N.J.) (01-08-2010)Get full text
Journal Article -
5
Blood pressure control in patients receiving bevacizumab in an outpatient cancer center
Published in Journal of oncology pharmacy practice (01-12-2011)“…Purpose. Hypertension is a common adverse effect of vascular endothelial growth factor (VEGF) signaling inhibitors, such as bevacizumab, with an incidence…”
Get full text
Journal Article -
6
Gemcitabine-induced gouty arthritis attacks
Published in Journal of oncology pharmacy practice (01-09-2013)“…In this case report, we review the experience of a patient who presented with early stage pancreatic cancer (Stage IIb) who underwent a Whipple procedure and…”
Get full text
Journal Article -
7
Impact of Primary Tumor Location on First-line Bevacizumab or Cetuximab in Metastatic Colorectal Cancer
Published in Reviews on recent clinical trials (2018)“…Colorectal cancer is one of the most common malignancies in the United States, with a large proportion of patients presenting with metastatic disease or…”
Get more information
Journal Article